0001493152-18-014009.txt : 20181002 0001493152-18-014009.hdr.sgml : 20181002 20181002172005 ACCESSION NUMBER: 0001493152-18-014009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181001 FILED AS OF DATE: 20181002 DATE AS OF CHANGE: 20181002 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GLECKEL LOUIS MD CENTRAL INDEX KEY: 0001164762 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21617 FILM NUMBER: 181102570 MAIL ADDRESS: STREET 1: C/O PROHEALTH CARE ASSOCIATES LLP STREET 2: 2800 METRUS AVE CITY: LAKE SUCCESS STATE: NY ZIP: 11042 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232577138 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 BUSINESS PHONE: 2153450919 MAIL ADDRESS: STREET 1: 621 N. SHADY RETREAT ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18901 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 4 1 ownership.xml X0306 4 2018-10-01 0 0000868278 ProPhase Labs, Inc. PRPH 0001164762 GLECKEL LOUIS MD 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 1 0 0 0 Common Stock, par value $0.0005 2018-10-01 4 A 0 3737 3.01 A 86709 D These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for quarterly director fees payable to non-employee directors. /s/ Louis Gleckel, MD 2018-10-02